ARMATA PHARMACEUTICALS, INC. Common Stock, Capital Shares Reserved for Future Issuance
ARMATA PHARMACEUTICALS, INC. (ARMP) had Common Stock, Capital Shares Reserved for Future Issuance of 46.34 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-12
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 46.34M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 46.10M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 44.11M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 42.10M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 46.34M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 46.10M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 44.11M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 42.10M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 41.73M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 41.33M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 49.66M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 49.26M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 48.89M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 48.60M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 46.40M shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 26.36M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 26.37M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 24.62M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 24.51M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 24.61M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 24.54M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 25.16M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 19.33M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 19.35M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 19.38M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 19.42M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 12.43M shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 12.36M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 12.39M shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 12.39M shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 3.20M shares 10-K · filed 2020-03-19 |
| 2019-09-30 | 3.21M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 3.21M shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 29.77M shares 10-Q · filed 2019-05-06 |
| 2018-12-31 | 28.60M shares 10-K · filed 2019-03-25 |
| 2018-09-30 | 9.94M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 9.94M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 9.95M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 9.67M shares 10-K · filed 2018-03-14 |
| 2017-09-30 | 9.85M shares 10-Q · filed 2017-11-14 |
| 2017-06-30 | 9.32M shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 1.12M shares 10-Q · filed 2017-05-15 |
| 2016-12-31 | 10.23M shares 10-K · filed 2017-03-27 |
| 2016-09-30 | 4.95M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 4.83M shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 2.77M shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 2.60M shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 2.60M shares 10-Q · filed 2015-11-16 |
| 2015-06-30 | 2.36M shares 10-Q · filed 2015-08-13 |
| 2015-03-31 | 124.60M shares 10-Q · filed 2015-05-15 |
| 2014-12-31 | 100.18M shares 10-K · filed 2015-04-15 |
| 2014-03-31 | 104.15M shares 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |